The iFuse is a titanium implant coated with a porous plasma spray acting as an interference surface fit to decrease implant motion. SI-BONE received original clearance in November 2008 from the FDA to market iFuse and an updated clearance in April 2011 for additional conditions including sacroiliac joint disruptions and degenerative sacroiliitis. The CE mark for European commercialization was obtained in November 2010.
More Articles on Orthopedic Devices:
20 Spine Devices Receive FDA 510(k) Clearance in June
Maxx Medical’s Freedom Total Knee System Now Available in China
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.